Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Ligand Third Quarter 2020 Earnings Webcast

More Info »
Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand Reports Third Quarter 2020 Financial Results

Read More

Ligand’s Captisol Technology Plays Key Role in the Manufacture of Gilead’s Veklury, the First FDA-Approved COVID-19 Treatment

Read More

Ligand Provides Highlights from Today’s Investor Day Event

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range